{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:45:25Z","timestamp":1784205925571,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Foundation","doi-asserted-by":"publisher","award":["1DH2111185"],"award-info":[{"award-number":["1DH2111185"]}],"id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["DE 614\/16-1"],"award-info":[{"award-number":["DE 614\/16-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ctro.2025.100941","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:32:46Z","timestamp":1740745966000},"page":"100941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases \u2013 Which patients do really benefit from an MR-linac?"],"prefix":"10.1016","volume":"52","author":[{"given":"Philipp","family":"Hoegen-Sa\u00dfmannshausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Katharina","family":"Renkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Hin","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Neugebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Niebuhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Buchele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Sandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Hoeltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Weykamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Regnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Liermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Meixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sedlaczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Peter","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kl\u00fcter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2025.100941_b0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0010","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2025.100941_b0015","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","author":"Gomez","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctro.2025.100941_b0020","author":"Tsai","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2025.100941_b0025","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2018.12.005","article-title":"Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies","volume":"131","author":"Rim","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.602607","article-title":"NRG oncology survey on practice and technology use in SRT and SBRT delivery","volume":"10","author":"Chetvertkov","year":"2020","journal-title":"Front. Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1117874","article-title":"MRI-LINAC: A transformative technology in radiation oncology","volume":"13","author":"Ng","year":"2023","journal-title":"Front. Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246041","article-title":"Dosimetric benefit of adaptive magnetic resonance-guided stereotactic body radiotherapy of liver metastases","volume":"14","author":"Weykamp","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2025.100941_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13071523","article-title":"Feasibility and early clinical experience of online adaptive mr-guided radiotherapy of liver tumors","volume":"13","author":"Rogowski","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2025.100941_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-021-01813-6","article-title":"Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis","volume":"16","author":"Mayinger","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0060","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00066-020-01578-z","article-title":"First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany","volume":"196","author":"Kl\u00fcter","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2025.100941_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacr.2008.07.011","article-title":"Randomized prospective trials of innovative radiotherapy technology are necessary","volume":"6","author":"Halperin","year":"2009","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.ctro.2025.100941_b0070","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac1ef2","article-title":"Toward MR-integrated proton therapy: Modeling the potential benefits for liver tumors","volume":"66","author":"Moteabbed","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2025.100941_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184592","article-title":"Comparing predicted toxicities between hypofractionated proton and photon radiotherapy of liver cancer patients with different adaptive schemes","volume":"15","author":"Nenoff","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2025.100941_b0080","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.33478","article-title":"Biologically Equivalent Dose Comparison Between Magnetic Resonance-Guided Adaptive and Computed Tomography-Guided Internal Target Volume-Based Stereotactic Body Radiotherapy for Liver Tumors","author":"Yoda","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ctro.2025.100941_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-022-02033-2","article-title":"MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial","volume":"17","author":"Hoegen","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0090","doi-asserted-by":"crossref","unstructured":"3. Definition of Volumes. J ICRU 2014;14:55\u201363. https:\/\/doi.org\/10.1093\/jicru_ndx003.","DOI":"10.1093\/jicru_ndx003"},{"key":"10.1016\/j.ctro.2025.100941_b0095","doi-asserted-by":"crossref","unstructured":"Okunieff P, Morgan D, Niemierko A, Suit HD. 0 Oncology Intelligence RADIATION DOSE-RESPONSE OF HUMAN TUMORS. vol. 32. 1995.","DOI":"10.1016\/0360-3016(94)00475-Z"},{"key":"10.1016\/j.ctro.2025.100941_b0100","article-title":"Local control after stereotactic body radiation therapy for liver tumors","author":"Ohri","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100941_b0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2012.07.002","article-title":"Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas","volume":"106","author":"Gevaert","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0360-3016(87)90266-5","article-title":"Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms","volume":"13","author":"Lyman","year":"1987","journal-title":"Internat. J. Radiat. Oncolo. Biol. Phys."},{"key":"10.1016\/j.ctro.2025.100941_b0115","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","article-title":"Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method gerald","volume":"16","author":"Kutcher","year":"1989","journal-title":"Internat. J. Radiat. Oncolo. Biol. Phys."},{"key":"10.1016\/j.ctro.2025.100941_b0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Internat. J. Radiat. Oncolo. Biol. Phys."},{"issue":"53","key":"10.1016\/j.ctro.2025.100941_b0125","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model.[see comment][erratum appears in Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1422]","volume":"2002","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100941_b0130","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"A nssessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach - The albi grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0135","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2020.04.027","article-title":"Dosimetric analysis and normal-tissue complication probability modeling of child-pugh score and albumin-bilirubin grade increase after hepatic irradiation","volume":"107","author":"Pursley","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100941_b0140","doi-asserted-by":"crossref","first-page":"S217","DOI":"10.1016\/S0360-3016(03)01031-9","article-title":"Analysis of radiation-induced gastric and duodenal bleeds using the Lyman-Kutcher-Burman model","volume":"57","author":"Pan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100941_b0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2017.04.024","article-title":"Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data","volume":"123","author":"Holyoake","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0150","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijrobp.2009.09.075","article-title":"A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer","volume":"78","author":"Murphy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100941_b0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: A concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"10.1016\/j.ctro.2025.100941_b0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejmp.2007.07.001","article-title":"A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy","volume":"23","author":"Gay","year":"2007","journal-title":"Phys Med"},{"key":"10.1016\/j.ctro.2025.100941_b0165","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/cncr.25997","article-title":"Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2025.100941_b0170","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4191-2","article-title":"The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): Patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases","volume":"18","author":"Andratschke","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2025.100941_b0175","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00066-024-02254-2","article-title":"Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO\/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery","volume":"200","author":"Brunner","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2025.100941_b0180","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ijrobp.2020.11.045","article-title":"The Dutch\u2013Belgian registry of stereotactic body radiation therapy for liver metastases: clinical outcomes of 515 patients and 668 metastases","volume":"109","author":"M\u00e9ndez Romero","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2025.100941_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-018-0969-2","article-title":"Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch\u00ae Patient Registry","volume":"13","author":"Mahadevan","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00066-021-01854-6","article-title":"Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility","volume":"198","author":"Sun","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2025.100941_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020270","article-title":"MR-LINAC, a new partner in radiation oncology: current landscape","volume":"16","author":"Ocanto","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2025.100941_b0200","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S1470-2045(20)30034-6","article-title":"MRI-guided adaptive radiotherapy for liver tumours: visualising the future","volume":"21","author":"Witt","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109932","article-title":"Gating and intrafraction drift correction on a 1.5 T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors","volume":"189","author":"Grimbergen","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.radonc.2014.11.033","article-title":"Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: A systematic review and meta-analysis","volume":"114","author":"Qi","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0215","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1088\/0031-9155\/53\/9\/003","article-title":"Quantification of interplay effects of scanned particle beams and moving targets","volume":"53","author":"Bert","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2025.100941_b0220","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1088\/0031-9155\/57\/7\/1779","article-title":"Respiratory liver motion estimation and its effect on scanned proton beam therapy","volume":"57","author":"Zhang","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ctro.2025.100941_b0225","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s11596-023-2717-6","article-title":"Comprehensive treatment uncertainty analysis and PTV margin estimation for fiducial tracking in robotic liver stereotactic body radiation therapy","volume":"43","author":"Wen","year":"2023","journal-title":"Curr. Med Sci"},{"key":"10.1016\/j.ctro.2025.100941_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.573279","article-title":"Feasibility of optical surface-guidance for position verification and monitoring of stereotactic body radiotherapy in deep-inspiration breath-hold","volume":"10","author":"Naumann","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1259\/bjr.20200859","article-title":"Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold","volume":"93","author":"Stick","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2025.100941_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.868076","article-title":"Association between internal organ\/liver tumor and external surface motion from cine MR Images on an MRI-Linac","volume":"12","author":"Mao","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0245","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00066-018-1271-9","article-title":"Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT","volume":"194","author":"Boda-Heggemann","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2025.100941_b0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4143\/crt.2017.594","article-title":"Long-term survival in patients treated with a robotic radiosurgical device for liver metastases","volume":"51","author":"Stintzing","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ctro.2025.100941_b0255","unstructured":"Kl\u00fcter S, Spindeldreier CK, Fees A, Major G, Debus J, Alber M, et al. PO-1033 What is required to make logfile-based Monte Carlo a viable QA method for realtime plan adaptation? n.d."},{"key":"10.1016\/j.ctro.2025.100941_b0260","article-title":"Leaf-individual calibration for a double stack multileaf collimator in photon radiotherapy","volume":"27","author":"Rippke","year":"2023","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0265","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.radonc.2017.07.028","article-title":"Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer","volume":"125","author":"Bohoudi","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0270","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.adro.2018.08.005","article-title":"A multi-institutional experience of MR-guided liver stereotactic body radiation therapy","volume":"4","author":"Rosenberg","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0275","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0280","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.radonc.2017.03.014","article-title":"Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases","volume":"123","author":"Klement","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.100941_b0285","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.4103\/jcrt.JCRT_956_16","article-title":"Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system","volume":"15","author":"Senthilkumar","year":"2019","journal-title":"J Cancer Res Ther"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082500031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082500031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:31:29Z","timestamp":1762623089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082500031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":57,"alternative-id":["S240563082500031X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.100941","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective planning comparison of magnetic resonance-guided vs. internal target volume-based stereotactic body radiotherapy of hepatic metastases \u2013 Which patients do really benefit from an MR-linac?","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.100941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100941"}}